Article Details

Helix BioPharma announces reduced loss and R&D spend in fiscal first quarter

Retrieved on: 2020-12-16 13:15:57

Tags for this article:

Click the tags to see associated articles and topics

Helix BioPharma announces reduced loss and R&D spend in fiscal first quarter. View article details on hiswai:

Excerpt

Helix <b>BioPharma</b> Corp (TSE:HBP) (OTCMKTS:HBPCF) (FRA:HBP), the clinical-stage <b>biopharma</b>, issued its first-quarter to October 31 results on ...

Article found on: www.proactiveinvestors.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up